Islay Capital Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Islay Capital Management's EDIT Position: Q3 2026 in Review
Islay Capital Management sold out of Editas Medicine (EDIT) in Q3 2026, closing a stake of 150 shares — an estimated $486 sold.
Islay Capital Management first reported a position in EDIT in Q3 2020 and held it in 23 quarters. The position peaked at $25K in Q4 2020. 221 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- Islay Capital Management reported no remaining Editas Medicine position as of Q3 2026 after selling out during the quarter.
- Islay Capital Management sold 150 Editas Medicine shares in Q3 2026, an estimated $486.
- Islay Capital Management first reported a position in Editas Medicine in Q3 2020 and held it in 23 quarters.
- Islay Capital Management's Editas Medicine position peaked at $25K in Q4 2020.
- 221 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on Islay Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.